Harnessing mRNA Quality Insights: Essential Techniques For Rapid Drug Development

In this session, Vernal's Chief Scientific Officer and Founder Christian Cobaugh, Ph.D. examines the critical quality attributes of mRNA and LNPs that are pivotal to enhancing drug efficacy and safety. Among them, are several cutting-edge analytical techniques—like nanopore sequencing, mass spectrometry, and laser-induced fluorescence capillary gel electrophoresis—that are transforming the field.

By mastering these advanced methods and understanding CQAs, drug developers can confidently advance through the development pipeline, troubleshoot early, and achieve clinical success. Integrating comprehensive characterization data into your strategy will allow you to optimize formulations, identify potential issues sooner, and streamline your path to market.

Discover how mRNA quality and innovative analytics are essential in developing effective mRNA-based therapies, and join us on the journey to accelerating life-changing medicines by watching the full presentation below.